• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌患者院内静脉血栓栓塞的危险因素:一项回顾性单中心研究。

Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study.

作者信息

Yang Huitang, Zhang Tonghe, Li Zhaoyang, Cai Yandong, Jiang Zhan, Fan Guoju, Wang Kaiqiang, Chen Bo, Zhang Hongwei, Hu Hailong, Li Yankui

机构信息

Department of Vascular Surgery, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.

Center for Cardiovascular Diseases, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.

出版信息

BMC Cancer. 2025 Mar 24;25(1):536. doi: 10.1186/s12885-025-13939-x.

DOI:10.1186/s12885-025-13939-x
PMID:40128752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11934594/
Abstract

OBJECTIVE

In this study, we retrospectively analyzed the incidence of and risk factors for in-hospital venous thromboembolism (VTE) in patients with bladder cancer and explored measures to reduce the incidence of and/or prevent in-hospital VTE and mortality.

METHODS

The clinical data of 5744 patients with bladder cancer who were admitted to the Second Hospital of Tianjin Medical University during a 5-year period were summarized and then analyzed to determine the risk factors for in-hospital VTE in patients with bladder cancer with the aim of identifying preventive measures.

RESULTS

Univariate analysis revealed significant differences between the VTE group and the non-VTE group in terms of age, sex, Caprini score, surgical treatment status, tumor stage, D-dimer level, PT, APTT, and Hb (P < 0.05). Multiple factor analysis further confirmed that the Caprini score, surgical treatment status, D-dimer level, PT, and APTT were independent risk factors for VTE.

CONCLUSION

Analyses revealed that a high Caprini score, surgical treatment, an elevated D-dimer level, a short PT, and a short APTT were independent risk factors for in-hospital VTE in patients with bladder cancer and that active preventive measures should be implemented to reduce the incidence of in-hospital VTE as well as mortality.

摘要

目的

本研究回顾性分析膀胱癌患者院内静脉血栓栓塞症(VTE)的发生率及危险因素,并探索降低院内VTE发生率和/或预防其发生及降低死亡率的措施。

方法

总结天津医科大学第二医院5年内收治的5744例膀胱癌患者的临床资料,然后进行分析以确定膀胱癌患者院内VTE的危险因素,旨在确定预防措施。

结果

单因素分析显示,VTE组与非VTE组在年龄、性别、Caprini评分、手术治疗情况、肿瘤分期、D-二聚体水平、PT、APTT和Hb方面存在显著差异(P < 0.05)。多因素分析进一步证实,Caprini评分、手术治疗情况、D-二聚体水平、PT和APTT是VTE的独立危险因素。

结论

分析显示,高Caprini评分、手术治疗、D-二聚体水平升高、PT缩短和APTT缩短是膀胱癌患者院内VTE的独立危险因素,应采取积极的预防措施以降低院内VTE的发生率及死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/11934594/3449e5d5b06a/12885_2025_13939_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/11934594/3449e5d5b06a/12885_2025_13939_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9724/11934594/3449e5d5b06a/12885_2025_13939_Fig1_HTML.jpg

相似文献

1
Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study.膀胱癌患者院内静脉血栓栓塞的危险因素:一项回顾性单中心研究。
BMC Cancer. 2025 Mar 24;25(1):536. doi: 10.1186/s12885-025-13939-x.
2
Application value of Caprini risk assessment model and elevated tumor-specific D-dimer level in predicting postoperative venous thromboembolism for patients undergoing surgery of gynecologic malignancies.Caprini风险评估模型及肿瘤特异性D-二聚体水平升高在预测妇科恶性肿瘤手术患者术后静脉血栓栓塞中的应用价值
J Obstet Gynaecol Res. 2019 Mar;45(3):657-664. doi: 10.1111/jog.13832. Epub 2018 Nov 4.
3
The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients.原始和改良的 Caprini 评分在 COVID-19 患者中同样可以预测静脉血栓栓塞症。
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1371-1381.e4. doi: 10.1016/j.jvsv.2021.02.018. Epub 2021 Mar 17.
4
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.术后D-二聚体可预测接受泌尿外科肿瘤手术患者的静脉血栓栓塞。
Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26.
5
[Risk factors of lung cancer complicated with symptomatic venous thromboembolism].[肺癌合并有症状静脉血栓栓塞症的危险因素]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Jun;39(6):454-8. doi: 10.3760/cma.j.issn.1001-0939.2016.06.010.
6
Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.比较 Khorana 预测评分和 Caprini 风险评估模型在评估住院癌症患者静脉血栓栓塞风险中的应用:一项回顾性病例对照研究。
Interact Cardiovasc Thorac Surg. 2020 Oct 1;31(4):454-460. doi: 10.1093/icvts/ivaa137.
7
Evaluation of risk factors for venous thromboembolism in Chinese women with epithelial ovarian cancer.评估中国上皮性卵巢癌女性静脉血栓栓塞症的危险因素。
Int J Gynecol Cancer. 2013 Jan;23(1):65-72. doi: 10.1097/IGC.0b013e318276dd87.
8
Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study.结直肠癌术后静脉血栓栓塞症风险评估模型的构建:一项中国单中心研究。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296211073748. doi: 10.1177/10760296211073748.
9
The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients.卡普里尼风险评估量表与血栓形成生物标志物相结合以评估重症患者静脉血栓栓塞风险
Medicine (Baltimore). 2018 Nov;97(47):e13232. doi: 10.1097/MD.0000000000013232.
10
Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors.比较新型炎症性肠病静脉血栓栓塞并发症预测因子与当前预测因子。
J Gastroenterol Hepatol. 2019 May;34(5):870-879. doi: 10.1111/jgh.14472. Epub 2018 Oct 22.

引用本文的文献

1
Elevated C-reactive protein and D-dimer to predict venous thromboembolism in patients with bladder cancer.高敏C反应蛋白和D-二聚体用于预测膀胱癌患者静脉血栓栓塞
Front Immunol. 2025 Aug 13;16:1652139. doi: 10.3389/fimmu.2025.1652139. eCollection 2025.

本文引用的文献

1
European guidelines on peri-operative venous thromboembolism prophylaxis: first update.: Chapter 12: Urology.欧洲围手术期静脉血栓栓塞预防指南:首次更新。第12章:泌尿外科。
Eur J Anaesthesiol. 2024 Aug 1;41(8):618-621. doi: 10.1097/EJA.0000000000002012. Epub 2024 Jul 10.
2
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs.美国开放性或微创手术前静脉血栓栓塞症对围手术期结局和医疗成本的影响:保险索赔数据分析。
Minerva Urol Nephrol. 2024 Jun;76(3):320-330. doi: 10.23736/S2724-6051.24.05699-4.
3
The Thresholds of Caprini Score Associated With Increased Risk of Venous Thromboembolism Across Different Specialties: A Systematic Review.
卡普里尼评分阈值与不同专业静脉血栓栓塞风险增加的相关性:系统评价。
Ann Surg. 2023 Jun 1;277(6):929-937. doi: 10.1097/SLA.0000000000005843. Epub 2023 Mar 13.
4
A Comprehensive Review of Risk Factors for Venous Thromboembolism: From Epidemiology to Pathophysiology.静脉血栓栓塞症风险因素的全面综述:从流行病学到病理生理学。
Int J Mol Sci. 2023 Feb 5;24(4):3169. doi: 10.3390/ijms24043169.
5
A Review of the Past, Present and Future of Cancer-associated Thrombosis Management.癌症相关血栓形成管理的过去、现在与未来综述
Heart Int. 2022 Aug 23;16(2):117-123. doi: 10.17925/HI.2022.16.2.117. eCollection 2022.
6
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.癌症患者的静脉血栓栓塞:ESMO临床实践指南
Ann Oncol. 2023 May;34(5):452-467. doi: 10.1016/j.annonc.2022.12.014. Epub 2023 Jan 10.
7
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.2022 年国际癌症患者静脉血栓栓塞症治疗和预防临床实践指南,包括 COVID-19 患者。
Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7.
8
Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review.根据治疗类型分析膀胱癌患者的静脉血栓栓塞发生率:一项系统评价
Cureus. 2022 Mar 8;14(3):e22945. doi: 10.7759/cureus.22945. eCollection 2022 Mar.
9
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.《癌症相关静脉血栓栓塞性疾病》,2021年第2版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2021 Oct 15;19(10):1181-1201. doi: 10.6004/jnccn.2021.0047.
10
Bladder Cancer: A Review.膀胱癌:综述。
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.